Loading
Loading
Coming soon: a clinical decision-support module that provides a patient-specific, source-backed treatment roadmap for breast cancer based on NCCN, ESMO and ASCO guidelines.
TreatMIND is the treatment planning module of the OncoEASE platform. It evaluates the patient's clinical, pathological and diagnostic data against a guideline-based decision graph and builds a structured roadmap for diagnosis/work-up, neoadjuvant, primary/locoregional, adjuvant and follow-up stages.
Every recommendation is shown alongside the verbatim guideline text it relies on; when data is missing, the system asks for it instead of guessing. ASCO germline and survivorship and ESMO HBOC recommendations are also covered, along with research-grade machine learning indicators and mCODE/FHIR export. TreatMIND supports the physician's decision and does not replace it. Intensive R&D is under way; it's coming soon.
Derives treatment options structured by care stage from clinical and pathological data.
Shows the NCCN, ESMO and ASCO guideline text verbatim; if data is missing, it asks for it instead of producing a recommendation.
Makes the diagnosis, neoadjuvant, primary, adjuvant and follow-up stages traceable in one flow.
Provides indicators such as survival risk tier, pCR likelihood, decision stability and the information value of missing data.
Exports structured data in mCODE / FHIR format, laying the groundwork for integration with hospital systems.
Fill in the form; we'll show you the product live on your own scenario and help you choose the right plan.
This product will be available for purchase very soon. Contact us for early access and launch benefits.
Contact Sales